Nippon Soda Co., Ltd.
4041・Prime Market・Chemicals
Chemical Materials
Nippon Soda's core manufacturing segment handling Industrial Chemicals, Chemical Products, Functional Materials, and pharmaceuticals
| Period | Current | Previous | Change |
|---|---|---|---|
| Net Sales (External Customers) | ¥37,406 million | ¥36,442 million | ↑ |
| Segment Profit (Operating Income) | ¥5,720 million | ¥6,074 million | ↓ |
| Segment Assets | ¥99,404 million | ¥95,531 million | ↑ |
| Depreciation | ¥3,974 million | ¥3,665 million | ↑ |
| Increase in Property, Plant and Equipment and Intangible Assets (Capital Expenditures) | ¥6,302 million | ¥6,493 million | ↓ |
Business Details
Comprises five categories: Industrial Chemicals (caustic soda, sodium cyanide, etc.), Chemical Products (color developers for thermal paper, secondary battery materials, etc.), Functional Materials (NISSO-PB, VP Polymer, etc.), Eco-Care Products (Bistolator, etc.), and Pharmaceuticals & Industrial Fungicides (NISSO HPC, Faropenem Sodium, etc.). Manufacturing is primarily conducted by the Company itself, with some outsourced to Nissoh Fine Co., Ltd. and others. Overseas sales are conducted through NISSO AMERICA INC. and NISSO CHEMICAL EUROPE GmbH. Expansion of high-value-added products is positioned as a core pillar of the medium-term strategy.
Recent Overview
Net sales increased, but operating income declined 5.8% year-on-year due to higher costs
In the Chemical Materials segment for FY2026 (ending March 2026), net sales were ¥37,406 million (up 2.6% year-on-year), and operating income was ¥5,720 million (down 5.8% year-on-year). Pharmaceuticals & Industrial Fungicides, Functional Materials, and Chemical Products contributed to increased revenue, while Industrial Chemicals (decline in sodium cyanide and caustic soda) and Eco-Care Products saw declines in revenue. Sales of sodium cyanide and the water treatment agent "Nisso Hicron" were discontinued as of FY2026. For the next fiscal year (FY2027, ending March 2027), steady performance is expected for NISSO HPC, NISSO-PB, and VP Polymer, but net sales are forecast to decline to ¥35,300 million.
Key Products
Growth Drivers
- Continued expansion of sales of the pharmaceutical excipient "NISSO HPC"
- Increasing demand for the KrF photoresist material "VP Polymer"
- Growth of the resin additive "NISSO-PB"
- Expansion of sales of non-phenolic color developers for thermal paper
- Global expansion through overseas sales networks (NISSO AMERICA and NISSO CHEMICAL EUROPE)
Risks
- Risk of declining revenue due to deteriorating market conditions for Industrial Chemicals (caustic soda, etc.) (sodium cyanide and Nisso Hicron have already been discontinued)
- Risk of rising manufacturing costs due to fluctuations in raw material and fuel prices
- Foreign exchange rate fluctuations (deterioration of export profitability amid yen appreciation)
- Continued investment recovery risk amid high levels of capital expenditure (¥6,302 million)
- Decline in export demand due to geopolitical risks or downturns in overseas economic conditions
- Risk of declining profit margins due to increased selling, general and administrative expenses (in FY2026, operating income declined despite increased revenue)
Last updated: June 25, 2026